<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282083</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT04282083</nct_id>
  </id_info>
  <brief_title>Database ITANET - ENETS Registry</brief_title>
  <official_title>Database ITANET (Italian Neuroendocrine Tumors Association) - ENETS Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Italian Association Neuroendocrine Tumors</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Italian Association Neuroendocrine Tumors</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study with the aim to create an Italian database for the
      collection of data on diagnostic approach, therapy and follow up of patients affected by
      GEP-NET (gastro-enteric-pancreatic neuroendocrine tumours) and to include these data into a
      multi-national European registry database, adhering to the ENETS (european neuroendocrine
      tumor society)-registry project.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each participating site will have access through the reserved area of webpage
      www.ita-net.org, where a proper link is enabled for the data recording in a database which
      ENETS set-up for the participating Sites in Europe, the ENETS-registry
      (https://www.enets-registry.eu/enets/).

      The eligible patients, visited at each participating site, will be asked to adhere to the
      ENETS-project through a proper Informed Consent obtainment procedure.

      The data will be collected in an anonymised way. Each patient will be identified by a code.

      The data management and quality check of the Italian data is deputed to ITANET. The data will
      be collected in a prospective way, both for the new diagnoses (first visits) and for the
      follow up visits of patients with already acquired diagnosis. The enrolment will take place
      during the outpatient visit or at the time of the hospitalisation for the NET-related
      surgery.

      Of course, considering the observational nature of the study, the follow up visits will be
      planned on the basis of each patient's clinical need, which is different patient by patient,
      according to the disease staging, the primary tumour location, the eventual surgery.

      The data flow will be the following:

        -  The participating site records the data in the database, waiting to be validated;

        -  ITANET has the role to check the recorded data for completeness and coherence in order
           to decide whether:

             1. The data are acceptable: in this case the validated data will be acquired from
                ENETS-registry;

             2. There are discrepancies: in this case a query will be sent to the related site in
                order to check, correct/explain where applicable and to resubmit the data. The
                process starts again until final validation.

      The data will be collected yearly to provide several information, such as:

        -  Type of NETs followed by the reference national sites for the management of the study
           pathology;

        -  Tools used for the diagnosis definition and the disease staging;

        -  Therapeutic approach (surgical or medical);

        -  Disease trend during follow up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 25, 2019</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of GEP-NET in Italy</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Different localisations of primary GEP-NET</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between symptoms appearance and diagnosis of GEP-NET</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Type of used and available treatments (medical and surgical)</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">3600</enrollment>
  <condition>Gastro-entero Pancreatic Neuroendocrine Tumors</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected by gastro-entero pancreatic neuroendocrine or unknown primary tumor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18 years

          -  histologically/cytologically proved diagnosis of NET

          -  Grading G1, G2, G3 according to the classification WHO 2017

          -  Tumor origin in digestive apparatus (GEP NETs) or tumor of unknown origin

          -  Signed Informed consent

        Exclusion Criteria:

          -  Known tumor origin different from digestive apparatus (GEP NETs)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MASSIMO FALCONI</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Raffaele Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Panzuto</last_name>
    <phone>+390633775605</phone>
    <email>fpanzuto@ospedalesantandrea.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Rinzivillo</last_name>
    <phone>+390633775605</phone>
    <email>mrinzivillo@ospedalesantandrea.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <state>Milan</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valeria Smiroldo</last_name>
      <phone>0039 02 8224 7731</phone>
      <email>valeria.smiroldo@cancercenter.humanitas.it</email>
    </contact>
    <contact_backup>
      <last_name>Erica Morgante</last_name>
      <phone>0039 02 8224 4095</phone>
      <email>erica.morgante@cancercenter.humanitas.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Consorziale Policlinico</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Cives</last_name>
      <phone>+390805592859</phone>
      <email>mauro.cives@uniba.it</email>
    </contact>
    <contact_backup>
      <last_name>Anna Ragno</last_name>
      <phone>+390805592759</phone>
      <email>ragnoanna@tiscali.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Campana</last_name>
      <phone>+390512143067</phone>
      <email>davide.campana@unibo.it</email>
    </contact>
    <contact_backup>
      <last_name>Giuseppe Lamberti</last_name>
      <phone>+390512143067</phone>
      <email>giuseppe.lamberti8@unibo.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore Carlo Alberto Pizzardi</name>
      <address>
        <city>Bologna</city>
        <zip>40133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MASSIMO FALCONI</last_name>
      <phone>3397473192</phone>
      <email>falconi.massimo@hsr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Nazionale Tumori</name>
      <address>
        <city>Milan</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Istituti Fisioterapici Ospitalieri</name>
      <address>
        <city>Roma</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sant'Andrea Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Panzuto</last_name>
      <phone>+390633775605</phone>
      <email>fpanzuto@ospedalesantandrea.it</email>
    </contact>
    <contact_backup>
      <last_name>Maria Rinzivillo</last_name>
      <phone>+390633775605</phone>
      <email>mrinzivillo@ospedalesantandrea.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GEP-NETs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroendocrine Tumors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

